Skip to main content
. 2020 Jul 10;99(28):e20654. doi: 10.1097/MD.0000000000020654

Figure 2.

Figure 2

Kaplan–Meier estimates OS according to the ALBI score in both training cohort (A) and validation cohort (B). In the training cohort and validation cohort, the median OS in patients with a pretreatment ALBI >−2.6 was significantly shorter than those of patients with a ALBI <−2.6. ALBI = albumin-bilirubin, OS = overall survival.